CHOLANGIOCARCINOMA, INTRAHEPATIC
Clinical trials for CHOLANGIOCARCINOMA, INTRAHEPATIC explained in plain language.
Never miss a new study
Get alerted when new CHOLANGIOCARCINOMA, INTRAHEPATIC trials appear
Sign up with your email to follow new studies for CHOLANGIOCARCINOMA, INTRAHEPATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Old gout drug tested as new hope for advanced liver cancer
Disease control CompletedThis phase 2 trial tested colchicine, a drug usually used for gout, in 42 people with advanced liver cancer that could not be treated with curative intent. Participants took colchicine tablets daily in cycles of 4 days on, 3 days off. The study measured how long patients survived…
Matched conditions: CHOLANGIOCARCINOMA, INTRAHEPATIC
Phase: PHASE2 • Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital • Aim: Disease control
Last updated Jun 26, 2026 14:59 UTC
-
New blood test could spare bile duct cancer patients unnecessary surgery
Diagnosis CompletedThis study tested a new blood test called LyMIC that looks for tiny particles (exosomes) released by cancer cells. The goal was to see if it could accurately tell whether bile duct cancer has spread to nearby lymph nodes before surgery. Researchers analyzed blood samples from 230…
Matched conditions: CHOLANGIOCARCINOMA, INTRAHEPATIC
Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 11:00 UTC